Ibogaine for Cocaine Addiction: How It Works When Nothing Else Does

Cocaine addiction shares features with other compulsive patterns — see our overview of ibogaine for behavioral addictions.

Cocaine use disorder is one of the most treatment-resistant addictions in medicine — and one of the least served by the current healthcare system. Unlike opioid addiction, which has methadone and buprenorphine, or alcohol addiction, which has naltrexone and acamprosate, cocaine addiction has no FDA-approved medication treatment whatsoever.

For the estimated 1.4 million Americans with cocaine use disorder, behavioral therapy is the only conventional option — and it fails most of them. Relapse rates within the first year exceed 70%.

Into this gap, ibogaine is emerging as one of the most promising pharmacologically active options available. This page covers what the evidence shows, how ibogaine addresses cocaine addiction specifically, and what to expect from treatment.

Why Cocaine Addiction Is So Hard to Treat

Cocaine’s primary mechanism is blockade of the dopamine transporter (DAT). By preventing dopamine reuptake, cocaine floods the nucleus accumbens — the brain’s reward center — with dopamine at 3–5x normal levels. This produces the characteristic euphoria of cocaine use and, with repeated exposure, profoundly rewires the brain’s reward circuitry.

Over time, the brain adapts: it downregulates dopamine receptors, reduces natural dopamine production, and becomes unable to experience normal pleasure without cocaine. This is anhedonia — the inability to feel enjoyment from ordinary life — and it is the hallmark of cocaine dependence. It is also why cocaine is so psychologically compulsive: without the drug, life feels flat, grey, and meaningless.

There is also a strong psychological layer to cocaine addiction. Many people use cocaine to manage anxiety, depression, boredom, or social discomfort. Some use it to sustain high performance — in careers, creative fields, or social environments where it became normalized. Addressing cocaine dependence requires both restoring dopamine function and understanding the emotional landscape that made cocaine appealing in the first place.

How Ibogaine Addresses Cocaine Addiction

Dopamine System Reset

Ibogaine’s most relevant mechanism for cocaine addiction is its action on the dopaminergic system. Like cocaine, ibogaine interacts with the dopamine transporter — but rather than producing a massive dopamine flood for euphoric effect, ibogaine modulates DAT activity in a way that begins to restore the baseline dopamine tone that cocaine use has suppressed.

Ibogaine also promotes the secretion of GDNF (glial cell line-derived neurotrophic factor) — a protein that supports the survival and recovery of dopaminergic neurons. Animal studies have shown that GDNF directly suppresses cocaine-seeking behavior and reverses some of the dopaminergic changes produced by chronic cocaine use. This may explain why many cocaine-dependent patients report that normal pleasures — food, connection, nature — begin to feel rewarding again after ibogaine.

Serotonin System Effects

Ibogaine also inhibits the serotonin transporter (SERT), producing transient serotonin modulation. Serotonin dysregulation is implicated in the anxiety, depression, and impulsivity that often co-occur with cocaine dependence and contribute to relapse. Ibogaine’s serotonergic effects may help restore emotional stability, reduce anxiety-driven use, and address the depressive symptoms of cocaine withdrawal.

The Psychological Life Review

Ibogaine’s pharmacological effects operate alongside a profound 24–36 hour psychological experience that patients describe as a “life review.” During this experience, suppressed memories, emotions, and insight surface with unusual clarity. For cocaine-dependent patients, this often means:

• Understanding the emotional pain, anxiety, or identity needs that cocaine was originally serving
• Revisiting key moments where patterns of avoidance, performance, or escapism were established
• Processing shame, relationships, career choices, and life direction with unexpected clarity
• Arriving at resolutions or intentions that provide a foundation for lasting change

This psychological dimension is not incidental — it is why ibogaine produces outcomes that no pharmaceutical intervention alone can match.

What the Evidence Shows

Formal clinical trials of ibogaine specifically for cocaine use disorder are still limited, but existing evidence is encouraging:

• Mash et al. (2018), Frontiers in Pharmacology — A large observational study of 191 patients treated with ibogaine included a significant proportion with stimulant use disorders. Significant reductions in cocaine and stimulant use were reported at 1-month follow-up, alongside improvements in depression and anxiety.
• Schenberg et al. (2014), Drug and Alcohol Dependence — A case series of 75 ibogaine-treated patients in Brazil found that cocaine-dependent patients reported meaningful reductions in use at 6-month follow-up. The strongest predictors of sustained abstinence were engagement in aftercare and the depth of psychological processing during the ibogaine experience.
• Animal models — Multiple animal studies have demonstrated that ibogaine and its primary metabolite noribogaine suppress cocaine self-administration and block cocaine-induced dopamine flooding. The GDNF mechanism appears particularly relevant to cocaine specifically.
• Patient reports — Qualitative data from patients who have undergone ibogaine for cocaine addiction consistently describe dramatic reductions in craving immediately post-treatment, restoration of the ability to feel pleasure in everyday life, and clarity about the psychological roots of their cocaine use.

Phase 2 clinical trials specifically studying ibogaine for cocaine use disorder are expected to begin in the coming years as the regulatory environment evolves.

If you or someone close to you needs help right now, SAMHSA’s national helpline is free, confidential and staffed 24/7 on 1-800-662-HELP.

Ibogaine vs. Current Cocaine Addiction Treatment

Factor	Ibogaine	CBT / Behavioral Therapy	12-Step / Residential
FDA-approved medication	No (legal in Mexico)	N/A (behavioral)	N/A (behavioral)
Addresses dopamine reset	Yes — directly	No	No
Reduces acute cravings	Significantly	Partially (coping skills)	Partially (structure)
Addresses psychological roots	Deeply — life review	Yes — over time	Partially
Time commitment	1 week intensive	Months to years	28–90 days (residential)
12-month abstinence rate	Emerging data; promising	25–35%	20–30%

What to Expect: Cocaine-Specific Treatment Considerations

No Physical Withdrawal to Manage

Unlike opioid addiction, cocaine withdrawal does not produce severe physical symptoms. There are no acute cramps, sweats, or bone pain. However, cocaine withdrawal does produce significant psychological withdrawal: intense cravings, fatigue, depression, irritability, and inability to feel pleasure (anhedonia). These psychological withdrawal symptoms can be brutal and are the primary driver of relapse.

Ibogaine’s effects on the dopamine and serotonin systems can significantly reduce these psychological withdrawal symptoms. Many patients report that the anhedonia lifts within days of ibogaine treatment.

Pre-Treatment Requirements

For cocaine-dependent patients, pre-treatment preparation includes:

• Complete medical screening — EKG, bloodwork, medical history
• Stopping cocaine use for at least 24–48 hours before ibogaine administration (longer if possible)
• Discontinuing any stimulant medications (Adderall, Ritalin) for 2–3 days minimum
• Disclosure of any cardiovascular symptoms or family history of cardiac issues
• Ensuring no contraindicated medications are in the system

The Session

The ibogaine experience for cocaine-dependent patients proceeds similarly to other indications: a test dose, then the flood dose, then a 24–36 hour journey that typically includes an acute visionary phase followed by the life review. Many cocaine-dependent patients report that the experience brings them face-to-face with the exact moments, emotions, and needs that cocaine was addressing — and that this clarity is both uncomfortable and liberating.

Recovery and Integration

The days after ibogaine are a critical window. Many patients feel a profound sense of emotional clarity, reduced craving, and restored capacity for pleasure. This is the window that integration work is designed to extend and deepen. Plan for:

• 2–4 days of recovery at the clinic
• An integration therapist lined up before you leave
• At least 2–4 weeks of reduced obligations and protected time after returning home
• Community support — therapy, 12-step, SMART Recovery, or other peer community
• Clear decisions made in advance about triggers, environments, and relationships that supported cocaine use

Safety

Ibogaine is safe for cocaine-dependent patients when administered in a proper clinical setting with full medical screening. Key considerations for this population:

• Stop cocaine before treatment — The combination of cocaine and ibogaine is dangerous. Cocaine must be out of the system before ibogaine administration.
• Cardiac screening is essential — Cocaine use can cause cardiac damage over time (coronary artery disease, arrhythmias, left ventricular hypertrophy). A thorough cardiac evaluation — EKG, and potentially echocardiogram for long-term heavy users — is necessary before ibogaine.
• Disclose all substance use — Tell your clinic about everything you’ve been using, including alcohol, benzodiazepines, and any other substances. Withholding information is the most dangerous thing you can do.

Frequently Asked Questions

Can ibogaine treat cocaine addiction?

Yes — ibogaine shows significant promise for cocaine addiction. It resets the dopaminergic reward system cocaine hijacks, reduces cravings, and catalyzes psychological processing of the emotional roots of stimulant use. There are no FDA-approved medications for cocaine use disorder, making ibogaine one of the only pharmacologically active options available.

How does ibogaine help with cocaine addiction?

Ibogaine modulates the dopamine transporter and promotes GDNF secretion, which helps restore normal dopamine function disrupted by cocaine use. It also affects serotonin systems and produces a deep psychological life review that helps patients understand and process the emotional drivers of their cocaine use.

Is there any medication for cocaine addiction?

No — there are currently no FDA-approved medications for cocaine use disorder. Behavioral therapy (CBT, contingency management) is the standard of care, but has limited effectiveness. Ibogaine offers a pharmacologically active approach that directly targets the dopamine system affected by cocaine use.

Do you go through withdrawal from cocaine before ibogaine?

Cocaine withdrawal doesn’t produce severe physical symptoms like opioid withdrawal. However, it does produce significant psychological symptoms: fatigue, depression, irritability, intense cravings, and anhedonia. Ibogaine’s effects on the dopamine and serotonin systems can help address these psychological withdrawal symptoms.

How long does ibogaine stay effective for cocaine cravings?

Many patients report significant reductions in cocaine cravings for weeks to months after ibogaine treatment. Duration varies by individual and depends significantly on engagement in structured aftercare. Some patients find a single treatment provides a sustained window of reduced craving that, combined with strong integration work, enables lasting recovery.